Electromyographic assessment of swallowing different types of clinical disease, Parkinson's on and off phases
Avaliação eletromiográfica da deglutição dos diferentes tipos clínicos da doença de Parkinson nas fases on e off
Douglas Monteiro; Maria das Graças Wanderley de Sales Coriolano; Luciana Rodrigues Belo; Etenildo Dantas Cabral; Amdore Guescel Asano; Otávio Gomes Lins
Abstract
Purpose: to evaluate the electromyographic parameters of swallowing different types of clinical stages of idiopathic Parkinson disease on and off.
Methods: the study was performed at the Clinic of Neurology, Hospital of the Federal University of Pernambuco. The population of the study were 20 patients with Parkinson disease, divided by Unified Scale for Assessment of Parkinson's disease in three groups: flickering, akinetic-rigid and mixed. The surface electromyography examination was collected on suprahyoid muscles during swallowing and 3 ml water and 10 ml of yoghurt, which was repeated 5 times for each volume and consistency. This protocol was carried out before and after the medication period off and on.
Results: it was found that the phase off, akinetic-rigid group had the highest average in parts of swallows and duration of surface electromyography, while the mixed group had the lowest average amplitude. In phase on the three groups tended to improve or maintain the averages of the variables, but there was no significant difference between the clinical types, before or after Levodopa.
Conclusion: drug therapy through Levodopa shows no consistent differences in surface electromyography of swallowing the clinical types of Parkinson disease.
Keywords
Resumo
Objetivo: avaliar os parâmetros eletromiográficos da deglutição dos diferentes tipos clínicos da doença de Parkinson idiopática nas fases on e off.
Métodos: foram estudados 20 pacientes com doença de Parkinson, divididos através da Escala Unificada de Avaliação da Doença de Parkinson em três grupos: tremulantes, rígido-acinético e misto. O exame de eletromiografia de superfície foi coletado sobre a musculatura supra-hióidea durante a deglutição de 3 ml e 10 ml de água e iogurte, que foi repetida 5 vezes para cada volume e consistência. Este protocolo foi realizado no antes e após a medicação, período off e on.
Resultados: verificou-se que na fase off, o grupo rígido-acinético apresentou as maiores médias de deglutições em partes e duração das eletromiografias de superfície, enquanto que o grupo misto apresentou as menores médias de amplitude. Na fase on, os três grupos tenderam a melhorar ou manter as médias das variáveis estudadas, porém não houve diferença significante entre os tipos clínicos, antes ou depois da Levodopa.
Conclusão: a terapia medicamentosa através da Levodopa não apresenta diferenças consistentes nas eletromiografias de superfície da deglutição dos tipos clínicos da doença de Parkinson.
Palavras-chave
Referências
1. Kansara S, Trivedi A, Chen S, Jankovic J, Le W. Early diagnosis and therapy of Parkinson's disease: can disease progression be curbed? Journal of Neural Transmission. 2012;120(1):197-210.
2. Barbosa ER, Sallem FAS. Doença de Parkinson – Diagnóstico (artigo de revisão). Neurociências. 2005;13(3):158-65.
3. Yamada EK, Siqueira KO, Xerez D, Koch HA, Costa MMB. A influência das fases oral e faríngea na dinâmica da deglutição. Arquivos de Gastroenterologia. 2004;41(1):18-23.
4. Gasparim AZ, Jurkiewicz AL, Marques JM, Santos RS, Marcelino PCO, Herrero-Junior F. Deglutição e tosse nos diferentes graus da doença de Parkinson. Arquivos Internacionais de Otorrinolaringologia. 2011;15(2):181-8.
5. Walker RW, Dunn JR, Gray WK. Self-reported dysphagia and its correlates within a prevalent population of people with Parkinson's disease. Dysphagia. 2011;26:92-6.
6. Ertekin C, Pehlivan M, Aydogdu I, Ertas LM, Uludag B, Çlelebi G et al. An electrophysiological investigation of deglutition in man. Muscle&Nerve. 1995;18:1177-86.
7. Bushmann M, Dobmeyer SM, Leeker L, Perlmutter JS. Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology. 1989;39:1309-14.
8. Steidl EMS, Ziegler JR, Ferreira FV. Doença de Parkinson revisão bibliográfica. Disc. Scientia. Série: Ciências da Saúde. 2007;8(1):115-29.
9. THE PARKINSON STUDY GROUP. Levodopa and progression of Parkinson's disease. New England Journal Medicine. 2004;351:2498-508.
10. Poewe W. The natural history of Parkinson's disease. Journal Neurology. 2006;253(2):2-6.
11. Azevedo LL, Cardoso F. Ação da levodopa e sua influência na voz e na fala de indivíduos com doença de Parkinson. Rev Soc Bras Fonoaudiol. 2009;14(1):136-41.
12. Robichaud JA, Kerstin D, Comella CL, Corcos DM. Effect of Medication on EMG Patterns in Individuals with Parkinson's Disease. Movement disorders. 2002;17(5):950-60.
13. Monte FS, Silva-Júnior FP, Braga-Neto P, Souza MAN, Bruin VMS. Swallowing abnormalities and dyskinesia in Parkinson's disease. Movement disorders. 2005;20:457-62.
14. Pullman SL, Goodin SD, Marquinez AI, Tabbal S, Rubin M. Clinical utility of surface EMG. Neurology. 2000;55:171-7.
15. Coriolano MGWS, Belo LR, Carneiro D, Asano AG, Oliveira PJA, Silva DM, et al. Swallowing in Patients with Parkinson's Disease: A Surface Electromyography Study. Dysphagia. 2012;27:550-5.
16. Hoehn MM, Yahr MD: Parkinsonism: onset, progression, and mortality. Neurology. 1967;17(5):427-42.
17. Fahn S, Elton RL, Committee. AMoutUD. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson's disease. New Jersey: Macmillan Healthcare Information. 1987. P.;153-63.
18. SENIAN: Surface ElectroMyoGraphy for the Non-Invasive Assessment of Muscles. Disponível em: <http://www.seniam.org/> Acesso em 26 jan. 2013.
19. Feodrippe P, Belo LR, Coriolano MGWS, Carneiro D, Lins OG. EMG BioanalyzerBR para a análise de sinais eletromiográficos na deglutição. Rev CEFAC. 2011;14(3):498-505.
20. Ertekin C, Aydogdu I, Yuceyar N, Tarlaci S, Kiylioglu N, Pehlivan M. et al. Electrodiagnostic methods for neurogenic dysphagia. Electroencephalography and clinical neurophysiology. 1998;109:331-40.
21. Wintzen AR, Badrising UA, Roos RAC, Vielvoye J, Liauw L. Influence of bolus volume on hyoid movements in normal individuals and patients with Parkinson's disease. Canadian Journal of Neurological Sciences. 1994;21:57-9.
22. Nilsson H, Ekberg O, Olsson R, Hindfelt B. Quantitative assessment of oral and pharyngeal function in Parkinson's disease. Dysphagia. 1996;11:144-50.
23. Aviles-Olmos I, Martinez-Fernandez R, Foltynie T. L-dopa-induced dyskinesias in Parkinson's disease. European neurological journal. 2010;2(2):91-100.
24. Pezzoli G, Zini M, Amrein R. L-dopa: the drug that changer the history of Parkinson's disease. Focus Parkinson's Disease. 2011;22(1):7-11.
25. Loureiro F. Alterações da deglutição em pacientes com doença de Parkinson: associação com a clínica e estudo eletrofisiológico simultâneo com a respiração [Tese]. Porto Alegre (RS): Universidade Católica do Rio Grande do Sul; 2011.
26. Gross RD, Atwood JR, Ross SB, Eichhorn KA, Olszewski JW, Doyle PJ. The coordination of breathing and swallowing in Parkinson's disease. Dysphagia. 2008;23:136-45.
27. Graham JM, Sagar HJ. A Data-Driven Approach to the Study of Heterogeneity in Idiopathic Parkinson's Disease: Identification of Three Distinct Subtypes. Movement Disorders. 1999;14(1):10-20.
28. Lewis SJG, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. Journal Neurology Neurosurgery Psychiatry. 2005;76:343-8.
29. Fuh J, Lee R, Wang S, Lin C, Wang P, Chiang J, Liu H. Swallowing difficulty in Parkinson's disease. Clinical neurology and neurosurgery. 1997;99:106-12.
30. Uitti RJ, Baba Y, Wszolek ZK, Putzke DJ. Defining the Parkinson disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. Journal Parkinsonism Relatated Disorders. 2005;11:139-45.
Submetido em:
14/04/2014
Aceito em:
15/07/2014
Facebook
Twitter
LinkedIn
Mendeley
Email